- News & Editorial
- Investor Relations
DPEC Subsidiary InvestBio, Inc., is Investor in Kinexis, a Life Sciences Company that Researches Proteins that May Help Treat Such Diseases as Alzheimer's and Parkinson's
NEW YORK CITY - January 23, 2008 - Scott Mathis, founder and chairman of Diversified Private Equity Corp. (DPEC), known as DPEC Partners, has been elected to the board of directors of Kinexis, Inc., a life sciences and R&D company that targets proteins that may be able to help treat neurodegenerative diseases such as Parkinson's and Alzheimer's.
DPEC Partners is the parent company of InvestBio, Inc., an organization focused on identifying and forming investment vehicles that enable selected accredited individual investors to participate in private equity investments in promising biotech companies. InvestBio has invested in Kinexis. Other investments include The Vaccine Company and AmpliMed.
Said Kevin Anderson, CEO at Kinexis, "Scott's record as an investor and biotech venture capitalist, makes him a valuable partner, advisor and addition to our board of directors."
Said Mr. Mathis, "I'm delighted to increase my involvement with Kinexis. I admire the company's accomplishments and the quality of its science and am excited about its potential. I'm honored to serve on the Kinexis board of directors."